Items where authors include "Quon, B."

Article

Keating, C., Yonker, L.M., Vermeulen, F. et al. (320 more authors) (2025) Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials. The Lancet Respiratory Medicine, 13 (3). pp. 256-271. ISSN 2213-2600

Acaster, S., Mukuria, C. orcid.org/0000-0003-4318-1481, Rowen, D. orcid.org/0000-0003-3018-5109 et al. (8 more authors) (2023) Development of the CFQ-R-8D: estimating utilities from the cystic fibrosis questionnaire-revised. Value in Health, 26 (4). pp. 567-578. ISSN 1098-3015

Flume, P.A., Biner, R.F., Downey, D.G. et al. (190 more authors) (2021) Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study. The Lancet Respiratory Medicine, 9 (7). pp. 733-746. ISSN 2213-2600